- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03259412
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance (FAT)
March 26, 2018 updated by: Lynsey Wilson, Loughborough University
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance, Inflammation, Gene Expression and Epigenetic Signatures
The aim of the study is to determine whether fish oil (specifically omega-3 long chain polyunsaturated fatty acids [EPA-DHA]) supplementation can enhance eccentric resistance exercise performance when combined with a resistance exercise training study.
The investigators aim to establish the potential mechanisms that might mediate performance changes at a cellular level.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leicester, United Kingdom, LE11 3TU
- Loughborough University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Males
- Healthy
Exclusion Criteria:
- Resistance exercise training within the past 6 months
- Vitamin or fish oil supplementation over the past 6 months
- Habitual use of anti-inflammatory drugs
- History of heart disease
- History of coagulation/bleeding disorder
- History of metabolic disease
- Serious allergy
- Known to have blood-borne virus
- Females (Due to differences in cell membrane incorporation of Omega-3 between the sexes and the testing schedule being unable to fit in with menstrual cycle, altering the blood markers that are being measured)
- Currently no symptoms of general illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fish Oil
Fish oil 5.1g/ day - Premium Omega-3, Norwegian Pure-3, Oslo, Norway
|
Fish Oil Capsule
Other Names:
|
Placebo Comparator: Placebo
Olive Oil 6g/ day - Premium Omega-3, Norwegian Pure-3, Oslo, Norway
|
Olive Oil capsule manufactured to mimic fish oil capsule
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Strength
Time Frame: Change from baseline strength at 11 weeks
|
Quadriceps and Hamstring strength using an isokinetic dynamometer
|
Change from baseline strength at 11 weeks
|
Leg power
Time Frame: Change from baseline strength at 11 weeks
|
Dynamic leg power assessed through jump height on force platform
|
Change from baseline strength at 11 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
December 20, 2017
Study Completion (Actual)
December 20, 2017
Study Registration Dates
First Submitted
August 4, 2017
First Submitted That Met QC Criteria
August 22, 2017
First Posted (Actual)
August 23, 2017
Study Record Updates
Last Update Posted (Actual)
March 27, 2018
Last Update Submitted That Met QC Criteria
March 26, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LoughboroughU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise-induced Inflammation
-
Appalachian State UniversityDole Food CompanyCompletedExercise-induced Inflammation | Exercise-induced Oxidative Stress | Exercise-induced Immune DysfunctionUnited States
-
Loughborough UniversityUniversity of WorcesterCompletedExercise-induced Inflammation
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
-
University of ThessalyCompletedSatellite Cells | Redox Status | Exercise-induced Muscle Trauma | Aseptic InflammationGreece
-
Johann Wolfgang Goethe University HospitalCompletedExercise-induced AsthmaGermany
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Antioxidant StatusGreece
-
Universitaire Ziekenhuizen KU LeuvenCompletedExercise Induced AsthmaBelgium
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Intracellular Signaling in Skeletal Muscle | Proteasome ActivationGreece
-
Norwegian University of Science and TechnologyKlinikk for allergi og luftveissykdommerCompletedExercise Induced BronchoconstrictionNorway
-
University of SaskatchewanRecruiting
Clinical Trials on Fish Oil
-
University of CopenhagenAnjo A/SCompletedObesity | Cardiovascular Disease | Metabolic Syndrome | Growth | Blood Pressure
-
DSM Nutritional Products, Inc.Completed
-
Rigshospitalet, DenmarkDanish Child Cancer FoundationRecruitingLeukemia, Acute LymphoblasticDenmark
-
National Science Council, TaiwanCompletedMajor Depressive DisorderTaiwan
-
Tufts UniversityPrevention PharmaceuticalsTerminated
-
Liverpool John Moores UniversityCompleted
-
Stanford UniversityNordic NaturalsCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedProteomics | Lipoprotein Metabolism | PCSK9United States
-
National Heart, Lung, and Blood Institute (NHLBI)UnknownMyocardial Tissue in Heart Transplantation
-
Melbourne HealthCompleted